Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Morbidity, mortality and antimicrobial resistance of pneumococcal infections in the Jamaican paediatric and adult populations

Morbidity, mortality and antimicrobial resistance of pneumococcal infections in the Jamaican... BACKGROUND:Pneumococcal infections are a leading global cause of morbidity and mortality, complicated by the increasing antimicrobial resistance of pneumococcal isolates.OBJECTIVE:To evaluate morbidity and mortality associated with both invasive pneumococcal disease (IPD) and non-IPD in Jamaica in both the paediatric and adult population. Pneumococcal isolates (n= 94) were collected over a 2-year period (2008–2009).METHODS:Risk factors for poor clinical outcomes: death, complicated disease and length of hospitalization (LOH) were evaluated and antimicrobial resistance patterns were determined by Kirby-Bauer disc diffusion.RESULTS:The case fatality rate was 6.8%. Independent mortality risk factors included complicated disease [OR 30.9 (3.4–276.6)] and diabetes mellitus [OR 8.3 (1.4–48.8)]. Independent risk factors for the development of complicated disease included sickle cell disease [OR 36.5 (4.2–320.3)] and sepsis [OR 3.5 (1.2–10.4)]. The LOH was increased most in patients with invasive disease (4.6-fold) and resistance to ceftriaxone (4.3-fold). Penicillin (16.0%) and erythromycin (14.9%) resistance was most prevalent, while ceftriaxone (4.3%) resistance was least prevalent.CONCLUSIONS:The high burden of IPD in at-risk groups in our population and the associated increase in morbidity and mortality underlie the need for improved preventive and therapeutic management strategies in these patients. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Human Antibodies IOS Press

Morbidity, mortality and antimicrobial resistance of pneumococcal infections in the Jamaican paediatric and adult populations

Loading next page...
 
/lp/ios-press/morbidity-mortality-and-antimicrobial-resistance-of-pneumococcal-i0kC1H6mxT

References (16)

Publisher
IOS Press
Copyright
Copyright © 2019 © 2019 – IOS Press and the authors. All rights reserved
ISSN
1093-2607
eISSN
1875-869X
DOI
10.3233/HAB-180361
Publisher site
See Article on Publisher Site

Abstract

BACKGROUND:Pneumococcal infections are a leading global cause of morbidity and mortality, complicated by the increasing antimicrobial resistance of pneumococcal isolates.OBJECTIVE:To evaluate morbidity and mortality associated with both invasive pneumococcal disease (IPD) and non-IPD in Jamaica in both the paediatric and adult population. Pneumococcal isolates (n= 94) were collected over a 2-year period (2008–2009).METHODS:Risk factors for poor clinical outcomes: death, complicated disease and length of hospitalization (LOH) were evaluated and antimicrobial resistance patterns were determined by Kirby-Bauer disc diffusion.RESULTS:The case fatality rate was 6.8%. Independent mortality risk factors included complicated disease [OR 30.9 (3.4–276.6)] and diabetes mellitus [OR 8.3 (1.4–48.8)]. Independent risk factors for the development of complicated disease included sickle cell disease [OR 36.5 (4.2–320.3)] and sepsis [OR 3.5 (1.2–10.4)]. The LOH was increased most in patients with invasive disease (4.6-fold) and resistance to ceftriaxone (4.3-fold). Penicillin (16.0%) and erythromycin (14.9%) resistance was most prevalent, while ceftriaxone (4.3%) resistance was least prevalent.CONCLUSIONS:The high burden of IPD in at-risk groups in our population and the associated increase in morbidity and mortality underlie the need for improved preventive and therapeutic management strategies in these patients.

Journal

Human AntibodiesIOS Press

Published: Jan 1, 2019

There are no references for this article.